Antibody Technologies Market Research Reports & Industry Analysis
Antibody technologies involve the use of specialized proteins called antibodies to target and detect specific molecules, often used in medical diagnostics, therapeutics, and research. This field is evolving quickly due to scientific advancements and the growing demand for personalized treatments. To help you stay updated on the latest developments, MarketResearch.com offers a comprehensive collection of reports on antibody technologies.
Valuable Antibody Technologies Research and Analysis
- Find detailed data on various market segments including precision medicine, biosimilars, biologics, protein engineering, and more.
- Obtain antibody technologies market sizing and growth projections, discussions of key drivers and challenges, pricing and regulatory analysis, and company profiles.
- Read expert commentary on recent technological innovations and industry trends to gain a clear understanding of emerging opportunities.
Your Research Partner
Whether you're an experienced industry professional, a consultant, or a busy executive, our antibody technologies market research reports are designed to help you make informed decisions. With reliable data and thorough analyses, these reports support your decision-making process. By choosing MarketResearch.com, you can gain the intelligence needed to stay competitive and take advantage of new opportunities.
Antibody Technologies Industry Research & Market Reports
-
Global Protein A Resin Market 2024-2028
... forecast period. The report on the protein A resin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Global Breast Cancer Monoclonal Antibodies Market 2024-2028
... on the breast Cancer monoclonal antibodies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033
... Lung Cancer; Brain Tumor4) By End User: Hospital; Clinics; Specialty CentersCovering: F. Hoffmann-La Roche Ltd.; Daiichi Sankyo Company Limited; Seagen Inc.; Gilead Sciences Inc.; Genmab Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033 ... Read More
-
Ion Channel Modulators
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Channel Blockers, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$12.4 Billion by ... Read More
-
Intravenous Immunoglobulin (IVIg)
... by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. IgA, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$13.7 Billion by the ... Read More
-
Cell Surface Markers
... by 2030, growing at a CAGR of 9.2% over the analysis period 2023-2030. Antibodies, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$981.1 Million by the ... Read More
-
Antibody Drug Conjugate - Market Insights, Competitive Landscape, and Market Forecast - 2030
... And Others), End-User (Hospitals And Specialty Cancer Centers, Biotechnology And Pharmaceutical Companies, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till ... Read More
-
Global Rituxan (Rituximab) Monoclonal Antibody Market Research Report 2024(Status and Outlook)
... and older with mature B-cell Non-Hodgkin's Lymphoma (NHL) and mature B-cell acute leukemia (B-AL): in combination with chemotherapy medicines. The Global Rituxan (Rituximab) Monoclonal Antibody Market Size was estimated at USD 4326.07 million in 2023 ... Read More
-
Global Biosimilar Monoclonal Antibody Market Research Report 2024(Status and Outlook)
... produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies. Biosimilar Monoclonal Antibodies refer to the biologic ... Read More
-
Monoclonal Antibodies
... at a CAGR of 6.8% over the analysis period 2023-2030. Human-sourced Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$105.2 Billion by the end ... Read More
-
Research ELISA (Enzyme-Linked Immunosorbent Assay)
... is expected to reach US$692.3 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.5% ... Read More
-
Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030
... America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of chronic diseases such as cancer, diabetes, and other autoimmune disorders, ... Read More
-
Biosensors
... of 7.1% over the analysis period 2023-2030. Non-wearable Biosensors, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$25.9 Billion by the end of the analysis period. ... Read More
-
Protein Engineering Market Report by Product & Services (Instruments, Reagents, Services and Software), Protein Type (Insulin, Monoclonal Antibodies, Coagulation Factors, Vaccines, Growth Factors, and Others), Technology (Irrational Protein Design, Rational Protein Design), End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations), and Region 2024-2032
... and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations), and Region 2024-2032 The global protein engineering market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.8 ... Read More
-
Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material
... 2024-2035. Bioreactors represent specialized vessels employed in upstream biomanufacturing to foster the growth of cells and tissues under precisely controlled conditions. These conditions encompass factors like temperature, pH, pressure, aeration, and nutrient levels, all aimed ... Read More
-
Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications
... during the forecast period 2024-2035. Rare kidney diseases encompass a spectrum of conditions, accounting to at least 150 distinct disorders. In Europe, a condition is deemed rare if its prevalence falls below 1 in 2000 ... Read More
-
COVID-19 Testing
... at a CAGR of -16.1% over the analysis period 2023-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.9% CAGR and reach US$3.9 Billion by the end ... Read More
-
Immunochemicals
... of 5.2% over the analysis period 2023-2030. Catalog Antibodies, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$4.6 Billion by the end of the analysis period. ... Read More
-
Tuberculosis Diagnostics Market Report by Disease Stage (Latent TB, Active TB), Test Type (Radiographic Test, Laboratory Test, Nucleic Acid Testing, Cytokine Detection Test, Drug Resistance Test, and Others), End-User (Hospitals and Clinics, Diagnostics and Research Laboratories, and Others), and Region 2024-2032
... Laboratories, and Others), and Region 2024-2032 The global tuberculosis diagnostics market size reached US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth ... Read More
-
Single-Use Bioreactors Market Report by Product Type (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Others), Type (Stirred-tank Bioreactors, Wave-induced Bioreactors, Bubble-column Bioreactors, and Others), Cell Type (Mammalian Cell, Bacteria, Yeast, and Others), Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, and Others), and Region 2024-2032
... (Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, and Others), and Region 2024-2032 The global single-use bioreactors market size reached US$ ... Read More
-
Gene Therapy Market Report by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide Gene, Deficiency, Growth Factors, Receptors, and Others), Vector Type (Viral Vector, Non-Viral Techniques), Delivery Method (In-Vivo Gene Therapy, Ex-Vivo Gene Therapy), Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Others), and Region 2024-2032
... Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Others), and Region 2024-2032 The global gene therapy market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach ... Read More
-
Cancer Immunotherapy Market Share, Size, Trends, Industry Analysis Report, By Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators); By Application; By End-User; By Region; Segment Forecast, 2024 - 2032
... market size is expected to reach USD 264.63 Billion by 2032, according to a new study by Polaris Market Research. The report “Cancer Immunotherapy Market Share, Size, Trends, Industry Analysis Report, By Type (Monoclonal Antibodies, ... Read More
-
Downstream Processing Market, By Technique (Purification Techniques, Solid-Liquid Separation, and Clarification/Concentration), By Product (Chromatography Columns and Resins, Filters, Evaporators, Centrifuges, and Other Products), By Application (Antibodies Production, Vaccines Production, Insulin Production, and Other Applications), By End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Downstream processing refers to the purification and recovery steps in bioprocessing undertaken ... Read More
-
2024 Global: Immunoprecipitation Market - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
-
Global Injectable Cytotoxic Drugs Market (2024 Edition): Market Size, Trends, Opportunities and Forecast By Drug Class (Plant Alkaloids, Alkylating Drugs, Antimetabolites, Cytotoxic Antibodies and Other Drug Classes), Application, Distribution Channel, Region, By Country: 2020-2030
... A report published by Azoth Analytics highlights different factors and opportunities prevailing in the “Global Injectable Cytotoxic Drugs Market (2024 Edition)”. According to the report, Global Injectable Cytotoxic Drugs Market valued at USD 18.3 Billion ... Read More
Research Assistance
